Abstract 9385: Longer History of Diabetes Attenuates Benefit of Low-Dose Aspirin for Primary Prevention of Cardiovascular Events: A subanalysis from the JPAD Trial

Sadanori Okada,Takeshi Morimoto,Hisao Ogawa,Masao Kanauchi,Mio Sakuma,Hirofumi Soejima,Masafumi Nakayama,Naofumi Doi,Atsushi Kubo,Yasuhiro Akai,Takahiro Kawano,Hideaki Jinnouchi,Masako Waki,Seigo Sugiyama,Shiro Uemura,Yoshihiko Saito

Abstract 9385: Longer History of Diabetes Attenuates Benefit of Low-Dose Aspirin for Primary Prevention of Cardiovascular Events: A subanalysis from the JPAD Trial

2011

Sadanori Okada
Takeshi Morimoto
Hisao Ogawa
Masao Kanauchi
Mio Sakuma
Hirofumi Soejima
Masafumi Nakayama
Naofumi Doi
Atsushi Kubo
Yasuhiro Akai
Takahiro Kawano
Hideaki Jinnouchi
Masako Waki
Seigo Sugiyama
Shiro Uemura
Yoshihiko Saito

Benefit of low-dose aspirin for primary prevention of cardiovascular events remains controversial in patients with diabetes. We have conducted the JPAD trial to evaluate whether low-dose aspirin co...

Keywords:

Cardiology
Diabetes mellitus
Internal medicine
Medicine
Aspirin
primary prevention
Type 2 diabetes
Clinical trial
Surgery
low dose aspirin
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations